TransGenRx signs $30 million deal with Argentinean firm

    Insider
    TransGenRx, a biotech firm that spun off of research at the LSU Ag Center, has signed a $30 million deal to produce human growth hormone for a pharmaceutical company based in Argentina. Cassara will b…

    We are glad you enjoy reading Business Report.

    Continue reading this story and get ACCESS to all our content from any device with a subscription now.

    • Get access to more than a decade of story archives.
    • Get access to our searchable data center of TOP LISTS.
    • Get exclusive content only available to INSIDERS.